Virtu KCG Holdings’s Agios Pharmaceuticals AGIO Stock Holding History

Virtu KCG Holdings’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$743K	Buy	+14,449	New	+$739K	0.02%	806
2016 Q3	–	Sell	-10,497	Closed	-$440K	–	3028
2016 Q2	$440K	Buy	10,497 +5,148	+96%	+$254K	0.01%	1487
2016 Q1	$217K	Buy	5,349 +1,785	+50%	+$76.3K	0.01%	2018
2015 Q4	$231K	Buy	+3,564	New	+$234K	﹤0.01%	2510
2015 Q3	–	Sell	-3,976	Closed	-$442K	–	3297
2015 Q2	$442K	Buy	+3,976	New	+$428K	0.01%	1608

Other funds holding AGIO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Virtu KCG Holdings's AGIO Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in Agios Pharmaceuticals (AGIO) in Q2 2017: 14,449 shares worth $743K. The stake represents 0.02% of the portfolio and ranks #806 among its holdings. This is a return to the name: Virtu KCG Holdings previously reported a position in AGIO as recently as Q2 2016.

Virtu KCG Holdings first reported a position in AGIO in Q2 2015 and has held it in 5 quarters since. 167 funds tracked by Wall St. Rank hold AGIO as of Q2 2017.

Virtu KCG Holdings held 14,449 shares of Agios Pharmaceuticals worth $743K as of Q2 2017.
Agios Pharmaceuticals was a new Virtu KCG Holdings position in Q2 2017.
Agios Pharmaceuticals made up 0.02% of Virtu KCG Holdings's portfolio in Q2 2017, its #806 holding.
Virtu KCG Holdings first reported a position in Agios Pharmaceuticals in Q2 2015 and has held it in 5 quarters since.
167 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.